Overview
Zhiyong Zeng practices practicing medicine in Fuzhou, China.
Their clinical expertise encompasses Multiple Myeloma, Mixed Connective Tissue Disease, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Esophageal Cancer.
They are actively involved in clinical research, co-authoring 34 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Zhiyong Zeng
Is Zhiyong Zeng a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Zhiyong Zeng is classified as an Experienced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Zhiyong Zeng participate in research or clinical trials?
Yes. Zhiyong Zeng has published 34 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Zhiyong Zeng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Esophageal CancerZeng isExperienced. Learn about Esophageal Cancer.
- Mixed Connective Tissue Disease
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaZeng isExperienced. Learn about Multiple Myeloma.